NIJ FY24 Research and Evaluation on Drugs and Crime: Money Laundering, Firearms, and Human Trafficking
ID: 352551Type: Posted
Overview

Buyer

National Institute of Justice (USDOJ-OJP-NIJ)

Award Range

$0 - $3M

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Feb 21, 2024 12:00 AM
  4. 4
    Due May 1, 2024 12:00 AM
Description

The National Institute of Justice (NIJ) is seeking applications for funding rigorous applied research on drugs and crime. The goal of this solicitation is to inform the development of evidence-based tools, practices, and policies for state, tribal, and local law enforcement and other criminal justice agencies. The focus is on addressing drug trafficking, drug markets, and drug-related violence. Specifically, NIJ is interested in better understanding drug crime organizations and networks and developing effective approaches to disrupt them. This includes targeting drug-related money laundering, firearms, and human trafficking. The funding instrument type for this opportunity is a Cooperative Agreement, and there is no cost sharing or matching requirement. The estimated total program funding is $3,000,000, with an expected number of awards being 4. The opportunity is open to units of local government, and the close date for applications is May 1, 2024. For more information and to apply, please visit the NIJ FY24 Research and Evaluation on Drugs and Crime: Money Laundering, Firearms, and Human Trafficking webpage. For assistance with the requirements of this solicitation, contact the OJP Response Center by phone at 800-851-3420 or 301-240-6310 (TTY for hearing-impaired callers only) or email grants@ncjrs.gov.

Point(s) of Contact
Files
No associated files provided.
Similar Opportunities
HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required)". This grant opportunity falls under the category of Health and is a Cooperative Agreement. The grant aims to address the overdose crisis in the context of the criminal justice system by increasing the delivery of and access to Medications for Opioid Use Disorder (MOUD) to justice-involved populations. Individuals in the US justice system are disproportionately likely to have Substance Use Disorder/Opioid Use Disorder (SUD/OUD) and are at high risk for opioid withdrawal upon incarceration. They are also at an elevated risk for overdose post-release if they have not received MOUD while detained. However, most US jails do not offer MOUD to everyone who could benefit from it. The HEAL Initiative's JCOIN Phase II Clinical Research Hubs focuses on translating research into practice to address the overdose crisis specifically within the criminal justice system. The grant aims to conduct hybrid effectiveness-implementation trials to overcome key barriers to delivering evidence-based OUD treatments to justice-involved populations. This grant opportunity is unique as it has a primary focus on justice-involved populations and criminal-legal systems. The grant does not require cost sharing or matching. The maximum award ceiling is $5,000,000. The eligibility for this grant opportunity extends to various entities, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions. Non-domestic (non-U.S.) entities and components are not eligible to apply. The closing date for this grant opportunity is January 22, 2025, and the archive date is February 27, 2025. For more information and to apply, please visit the following link: [HEAL Initiative: JCOIN Phase II Clinical Research Hubs Grant Opportunity](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-025.html). If you have any further inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.
HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)". This grant opportunity falls under the category of Health and is a Cooperative Agreement. The grant does not require cost sharing or matching. The purpose of this grant is to address the overdose crisis in the context of the criminal justice system, specifically focusing on justice-involved populations and criminal-legal systems. The grant aims to increase the delivery of and access to Medications for Opioid Use Disorder (MOUD) to individuals in the US justice system. It is important to note that individuals in the US justice system are disproportionately likely to have Substance Use Disorder/Opioid Use Disorder (SUD/OUD), and they are at high risk for opioid withdrawal upon incarceration and overdose post-release if they have not received MOUD while detained. The grant seeks to fund a portfolio of research projects that will conduct hybrid effectiveness-implementation trials to address key barriers to the delivery of evidence-based OUD treatments to justice-involved populations. The ultimate goal is to translate research into practice and improve the availability and accessibility of MOUD for this vulnerable population. The grant opportunity is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, non-domestic (non-U.S.) entities (foreign organizations) and non-domestic components of U.S. organizations are not eligible to apply. The closing date for this grant opportunity is January 22, 2025. The maximum award ceiling is $750,000. For more information and to apply, please visit the following link: [HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-026.html). For any further inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)". This grant aims to support pilot, feasibility, or exploratory research in substance use epidemiology and health services. The research will focus on five priority areas, including responses to sudden and severe emerging drug issues, responses to emerging marijuana trends and topics related to the shifting policy landscape, responses to unexpected and time-sensitive prescription drug abuse research opportunities, responses to unexpected and time-sensitive medical system issues, and responses to unexpected and time-sensitive criminal or juvenile justice opportunities that relate to drug abuse and access and provision of health care service. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities, U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Institutions) and non-domestic components of U.S. Organizations are not eligible to apply. The grant does not require cost sharing or matching requirements. The funding instrument type is a grant, and the category of funding activity is health. The maximum award ceiling is $275,000. The deadline for application submission is September 8, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-027.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-027.html). If you have any inquiries, you can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
OJJDP FY24 Community and Schools Youth Drug Prevention Program
Active
Office of Juvenile Justice Delinquency Prevention
The Office of Juvenile Justice Delinquency Prevention (OJJDP) has posted a grant opportunity titled "OJJDP FY24 Community and Schools Youth Drug Prevention Program". This program aims to support a National Community and Schools Youth Drug Prevention Program that delivers substance use prevention programs in schools in partnership with local law enforcement and community coalitions. The selected national organization will provide funding and training to local non-profits, who will be responsible for building community coalitions in collaboration with law enforcement to educate youth on drug prevention. The program emphasizes the importance of comprehensive approaches to prevent youth substance use through partnerships among non-profit organizations, community coalitions, and law enforcement. The grant does not require cost sharing or matching. The estimated total program funding is $10,000,000, with an expected number of awards being one. For-profit organizations are eligible to apply. The closing date for applications is August 12, 2024. For more information, please visit the [full announcement](https://ojjdp.ojp.gov/funding/opportunities/o-ojjdp-2024-172193).
Fiscal Year 2024 Competitive Cooperative Agreement Solicitation - Drug Court Training and Technical Assistance
Active
Office of National Drug Control Policy
The Office of National Drug Control Policy (ONDCP) has posted a fiscal year 2024 competitive cooperative agreement solicitation for Drug Court Training and Technical Assistance. This cooperative agreement aims to support training and technical assistance (TTA) that helps states, state courts, local courts, and units of local government with drug courts or considering drug courts develop, maintain, and enhance alternatives to incarceration for individuals with addiction. The service/item being procured is training and technical assistance to enhance alternatives to incarceration for individuals with addiction. The President's priority is to enhance public safety by providing those who have engaged in criminal activity with greater opportunities to lead productive lives by addressing a range of issues, including mental health, vocational training, job creation, after-school programming, substance use, and mentoring through evidence-based rehabilitation programs. ONDCP seeks to reduce drug use and its consequences through evidence-based practices, and this cooperative agreement will apply these principles to the criminal justice system. The close date for this opportunity is July 31, 2024. For more information, you can visit the following link: [Fiscal Year 2024 Competitive Cooperative Agreement Solicitation - Drug Court Training and Technical Assistance](https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=111308).